Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Lobe Sciences
Company

Lobe Sciences

Tracked across 2 events · 14 articles · First seen Apr 11, 2026 · Last active Aug 20, 2026

Sentiment
15
Attention
2
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
2 20
Business
Lobe Sciences Ltd. Closes Private Placement
Impact: Lobe Sciences announced and closed a non-brokered private placement, raising approximately $950,000 for working capital, general corporate purposes, and to advance its S-100 drug candidate.
Apr 11, 2026 · 7 articles
1 10
Business
Lobe Sciences Private Placement Closing
Lobe Sciences, a clinical-stage biopharmaceutical company, announced and closed a non-brokered private placement of 24,705,880 common shares at $0.085 per share, raising approximately $2.1 million. The proceeds will be used for working capital, general corporate…
Impact: Lobe Sciences is the issuer and primary beneficiary of the private placement, raising $2.1 million to fund operations and clinical development. The capital infusion supports its S-100 program and working capital needs.
Aug 12, 2026 · 7 articles
Key Actions (2)
90 Lobe Sciences announced private placementLobe Sciences Private...
60 Lobe Sciences allocated proceedsLobe Sciences Private...
ERGEN INTELLIGENCE
Track Lobe Sciences live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.